(1 - 17 from 18
)
Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform to...
news.thomasnet.com
Cancer Genetics Expands BioDiscoverys Nexus Copy Number Platform to Identify Novel Biomarkers Predictive of Cancer Outcomes - BioDiscovery, Inc.
Cancer Genetics (NASDAQ:CGIX) - Cancer Genetics, Inc. Releases The...
www.benzinga.com
CGI's proprietary genomic test has been CLIA and NYS licensed to stratify CLL and SLL patient into three distinct outcome groups: favorable, ...
Cancer Genetics, Inc. Will Open Precision Medicine Conference With...
www.globenewswire.com
... Jane Houldsworth, Ph.D., will provide the opening keynote presentation for the "Realizing the Potential of Precision Medicine" conference on ...
Cancer Genetics, Inc. Launches Webinar Series to Drive Awareness and...
www.globenewswire.com
CGI's webinar series, "An introduction to FHACT™: the FISH-based HPV-Associated Cancer Test," was designed by Jane Houldsworth, PhD, ...
sorted by relevance / date